FAPI PET-CT scan to find unknown primary cancer
Part of Cancer clinical trials.
This study tests a new type of PET-CT scan using a tracer called FAPI to find the original source of cancer when standard tests have not been able to. It may help identify the primary tumor in people with cancer that has spread from an unknown location.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have cancer that has spread (metastasized), but doctors cannot find where it started despite standard tests, including a PET-CT scan
- You have not had chemotherapy or other systemic therapy for this cancer of unknown origin
- You are not pregnant or breastfeeding
- You can lie still on your back for the PET-CT scan and are not severely claustrophobic
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a radioactive drug called Lu-177 FAP-2286 for people with cancer that started in an unknown place (CUP). It may help shrink tumors by targeting a protein found on many cancer cells.
This study uses a special PET scan (FAPI-PET) during routine workup to help detect tumors and decide how far they may have spread. You may be able to take part if you need a staging or restaging scan and can safely complete the imaging.
This trial tests a new type of PET scan (Ga68-FAPI-46) to better see if cancer from the colon, rectum, or ovary has spread to the lining of the belly. If you are already scheduled for surgery to remove these cancer spots, this scan may help your doctors plan a more complete operation.
This study uses a special type of PET/CT scan (FAPI) to get a better look at the environment around colorectal cancer that has spread to the liver. It may help doctors learn more about the tumor and plan treatment.
This trial tests a special scan (18F-FAPI PET) to help find where a cancer started when the origin is unknown. The goal is to better locate the hidden tumor and guide treatment.
This study tests a new type of PET scan that uses a special tracer called FAPI to find where cancer has spread in your body. It may help doctors see hidden tumors more clearly without needing extra treatments first.
Hear when a new Cancer of Unknown Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.